METABOLISM AND EXCRETION OF THE NOVEL ANTIPSYCHOTIC DRUG ZIPRASIDONE IN RATS AFTER ORAL-ADMINISTRATION OF A MIXTURE OF C-14-LABELED AND H-3-LABELED ZIPRASIDONE
C. Prakash et al., METABOLISM AND EXCRETION OF THE NOVEL ANTIPSYCHOTIC DRUG ZIPRASIDONE IN RATS AFTER ORAL-ADMINISTRATION OF A MIXTURE OF C-14-LABELED AND H-3-LABELED ZIPRASIDONE, Drug metabolism and disposition, 25(2), 1997, pp. 206-218
The metabolism and excretion of ziprasidone (5-[2-[4-(1,2-benzisothiaz
ol-3-yl)piperazin-1 -yl]ethyl]-6-chloroindolin-2-one hydrochloride hyd
rate) were studied in Long Evans rats after oral administration of a s
ingle dose of a mixture of C-14- and H-3-labeled ziprasidone. The radi
oactive dose was quantitatively recovered over 7 days in both male and
female rats, The percentage of the dose excreted in urine, bile, and
feces of rats was 21.6, 19.2, and 55.6%, respectively, The total excre
tion in urine and bile suggested that at least 41% of the drug was abs
orbed, Absorption of ziprasidone was rapid, and the mean plasma concen
trations of the unchanged drug and metabolites were slightly higher in
the female rats than in the males, The maximal plasma concentrations
for ziprasidone and metabolites were reached at 1 hr in both male and
female rats, Based on AUC (0-12 hr) values, approximately 59 and 52% o
f the circulating radioactivity (average of C-14 and H-3) was attribut
able to metabolites in male and female rats, respectively. Ziprasidone
was extensively metabolized in rats, and only a small amount of zipra
sidone was excreted as unchanged drug, Twelve metabolites were identif
ied by ion spray LC/MS, using a combination of parent ion and product
ion scanning techniques. The structures of eight metabolites were unam
biguously confirmed by coelution, on HPLC with synthetic standards, an
d four additional metabolites were partially identified, There was a g
ender-related difference in the excretion of urinary metabolites in Lo
ng Evans rats, The major route of metabolism in male rats involved N-d
ealkylation. In female rats the major metabolites were due to oxidatio
n at the benzisothiazole ring, Based on the structures of these metabo
lites, four major and two minor routes of metabolism of ziprasidone we
re identified. The major routes included 1) N-dealkylation of the ethy
l side chain attached to the piperazinyl nitrogen, 2) oxidation at the
sulfur, resulting in the formation of sulfoxide and sulfone, 3) oxida
tion on the benzisothiazole moiety (other than sulfur), and 4) hydrati
on of the C=N bond and subsequent oxidation at the sulfur of the benzi
sothiazole moiety. The minor routes involved N-oxidation on the pipera
zine ring and hydrolysis of the oxindole moiety.